The effect of bowel resection on survival in advanced epithelial ovarian cancer

Gynecologic Oncology

Volumn 83, Issue 2, 2001, Pages 286-291

  Jaeger, W ^a   Ackermann, S ^a   Kessler, H ^a   Katalinic, A ^b   Lang, N ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bowel 0 metastases; Bowel resection; Ovarian cancer; Surgical treatment

Indexed keywords

ADULT; ARTICLE; ASCITES; CANCER STAGING; FEMALE; HUMAN; INTESTINE RESECTION; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 0034766558     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6375     Document Type: Article

References (20)

1. Entwicklungen in der therapie des fortgeschrittenen ovarialkarzinoms FIGO III
2. Die rolle von darmresektion bei der erstoperation des ovarialkarzinoms
3. Die operative behandlung des ovarialkarzinoms
4. Intestinal surgery in primary or recurrent ovarian cancer
5. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer
6. The role of bowel surgery in the primary treatment of epithelial ovarian cancer
7. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma
8. Stage III epithelial ovarian cancer: The role of maximal surgical reduction
9. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer
10. Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphamide therapy in advanced ovarian adenocarcinoma
11. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
12. The prognostic significance of residual disease, FIGO substage, tumor histology and grade in patients with FIGO stage III ovarian cancer
13. Primary cytoreductive surgery for epithelial ovarian cancer
14. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study
15. Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?
16. Reproducibility of tumor measurements in ovarian cancer: A study of interobserver variability
17. Systemic aortic and pelvic lymphadenectomy versus resection of any bulky nodes in advanced ovarian cancer FIGO III and IV: A prospective trial
18. Modified posterior exenteration for ovarian cancer
19. Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidity
20. Long-term survival in stage III and IV ovarian cancer